Insights

Sustainable Bioprocessing Capra Biosciences focuses on cost-competitive biomanufacturing of high-value chemicals, signaling a strong fit for buyers seeking greener alternatives to petrochemicals and potential cross-sell of wastewater reduction and waste valorization services.

New Product Launch The May 2026 salicylic acid launch for personal care creates a short-term sales window to target personal care brands and contract manufacturers seeking sustainable ingredients with scalp- and skin-care performance benefits.

Strategic Partnerships Active collaborations with Boston University, Virginia Tech, Syracuse University, ATCC, and Next Rung Technology indicate a readiness to engage enterprise-grade research partners and license or co-develop capabilities for customers needing custom bioprocessing solutions.

Fabrication Platform The innovative bioreactor design aimed at reducing end-to-end manufacturing costs suggests a competitive differentiator that can be positioned to process developers, biotech sponsors, and scale-up manufacturers seeking lower production costs.

Tech Stack & Enablement Utilization of cloud, collaboration, and data analytics tools implies readiness to offer connected pilot programs, digital traceability, and data-driven fermentation optimization services to prospective clients.

Similar companies to Capra Biosciences

Capra Biosciences Tech Stack

Capra Biosciences uses 8 technology products and services including iCIMS, GitHub, Squarespace, and more. Explore Capra Biosciences's tech stack below.

Media & News

Capra Biosciences's Email Address Formats

Capra Biosciences uses at least 3 email formats:
Capra Biosciences Email FormatsExamplePercentage
First@caprabiosciences.comJohn@caprabiosciences.com
82%
LastF@caprabiosciences.comDoeJ@caprabiosciences.com
9%
FLast@caprabiosciences.comJDoe@caprabiosciences.com
9%

Frequently Asked Questions

What is Capra Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Capra Biosciences's official website is caprabiosciences.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Capra Biosciences generate?

Minus sign iconPlus sign icon
As of November 2026, Capra Biosciences's annual revenue is estimated to be $10M - $25M.

What is Capra Biosciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
Capra Biosciences's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Capra Biosciences have currently?

Minus sign iconPlus sign icon
As of November 2026, Capra Biosciences has approximately 27 employees across 1 continents, including North America. Key team members include Chief Executive Officer: E. O., Senior Biotech Engineer / Analyst: R. G. and Senior Scientist: J. L. Explore Capra Biosciences's employee directory with LeadIQ.

What industry does Capra Biosciences belong to?

Minus sign iconPlus sign icon
Capra Biosciences operates in the Biotechnology Research industry.

What technology does Capra Biosciences use?

Minus sign iconPlus sign icon
Capra Biosciences's tech stack includes iCIMS, GitHub, Squarespace, WordPress, Shopify, Google Workspace, Google Cloud and Piwik PRO Core.

What is Capra Biosciences's email format?

Minus sign iconPlus sign icon
Capra Biosciences's email format typically follows the pattern of First@caprabiosciences.com. Find more Capra Biosciences email formats with LeadIQ.

How much funding has Capra Biosciences raised to date?

Minus sign iconPlus sign icon
As of November 2026, Capra Biosciences has raised $22M in funding. The last funding round occurred on Aug 04, 2026.

When was Capra Biosciences founded?

Minus sign iconPlus sign icon
Capra Biosciences was founded in 2020.
Capra Biosciences logo

Capra Biosciences

Biotechnology ResearchVirginia, United States11-50 Employees

Capra Biosciences is a biotechnology research company developing a bioreactor approach intended to lower end-to-end manufacturing costs for chemicals produced via biology. It aims to make biobased chemicals competitive with petroleum-based products by addressing scale-up bottlenecks in production. Based in Sterling, Virginia, the company engages with academic and research partners to advance its technology, including collaborations with Boston University, Virginia Tech, Syracuse University, ATCC, and Next Rung Technology, often in a primary-contractor role. 

In May 2026, Capra announced the launch of a naturally derived salicylic acid for personal care applications at NYSCC Suppliers' Day. The firm operates within the biotechnology research space focused on sustainable domestic production of high-value chemicals and pursues partnerships to validate and refine its processes, including efforts around opportunistic consumption by switching between feedstocks.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $22M

    Capra Biosciences has raised a total of $22M of funding over 10 rounds. Their latest funding round was raised on Aug 04, 2026 as a Grant.

  • $10M - $25M

    Capra Biosciences's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.